PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

DISEASE CHARACTERISTICS: * Histological confirmation of 1 of the following: * Ovarian epithelial carcinoma * Fallopian tube cancer * Primary peritoneal cancer * Advanced colorectal carcinoma * Other malignancy confined to the peritoneal cavity or peritoneal surfaces * No lesion greater than 2 cm in greatest diameter based on surgical re-assessment * Low burden of tumor in the abdominal or pelvic cavities and no clinically significant ascites * Received potentially effective therapy when available (e.g., platinum/taxane for ovarian cancer, fluoropyrimidine-based therapy for colorectal cancer) * No concurrent hematological malignancy (e.g., chronic lymphocytic leukemia or non-Hodgkin's lymphoma) * No bilateral adrenal metastases * No adrenal metastases in the remaining adrenal gland after adrenalectomy (including radical nephrectomy) * No lung tumors 5 cm or more * No pleural effusions (at least 25% of hemithorax) by radiography * No CNS metastases by CT scan or MRI PATIENT CHARACTERISTICS: Age * 18 and over Performance status * Karnofsky 70-100% Life expectancy * More than 3 months Hematopoietic * WBC at least 3,000/mm\^3 * Absolute neutrophil count at least 1,000/mm\^3 * Platelet count at least 100,000/mm\^3 * Hemoglobin greater than 9 g/dL Hepatic * Bilirubin no greater than 1.5 times upper limit of normal (ULN) * AST and ALT no greater than 1.5 times ULN * Alkaline phosphatase no greater than 1.5 times ULN * No uncontrolled hepatic dysfunction * No ac…